Skip to main content
CDC Website

TB

TB

የዊንዶው ሕክምና ለሳምባ ነቀርሳ (TB) ከተጋለጡ በኋላ: ወላጆች ማወቅ ያለባቸው [Window Treatment: What Parents Need to Know]

The fact sheet includes information on window treatment for children after exposure to TB, such as how to help a child take isoniazid, potential side effects, and when to call a child's doctor. The material also lists symptoms of TB disease in children.

Window Treatment After Exposure to Tuberculosis: What Parents Need to Know

The fact sheet includes information on window treatment for children after exposure to TB, such as how to help a child take isoniazid, potential side effects, and when to call a child's doctor. The material also lists symptoms of TB disease in children. 

Nontuberculous Mycobacteria (NTM)

This handout describes nontuberculous mycobacteria (NTM), clinical manifestations, NTM diagnosis, treatment, and action required. The handout also includes 2019 data from the Virginia Department of Health TB Program and links to additional information.

COVID-19 and Tuberculosis

The handout provides information on the similarities and differences between COVID-19 and TB, lists who is at higher risk for TB, and includes additional recommendations. 

Bridges to Build: Improving TB Care for African American Patients

This 90-minute webinar focuses on how anti-black racism impacts African Americans' access to care and the quality of care they receive. The webinar also includes information on specific strategies for clinicians and programs to consider to improve TB care for African American patients.

City Health Information (CHI): Testing For and Treating Latent Tuberculosis Infection

This clinical bulletin provides information on testing for and treating latent TB information. The bulletin also includes resources for providers, resources for patients, and more! 

Latent TB: Updated Treatment Recommendations

In this video CDC's Dr. LoBue discussing the updated recommendations for the 12-dose treatment regimen for latent TB infection.

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Isoniazid y Rifapentine

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

TB Personal Stories - Kate

This story highlights the personal experiences of a Tuberculosis (TB) survivor who was diagnosed and treated for TB disease. The survivor details the challenges of a lengthy hospital stay, her worries over how TB medicines would affect her pregnancy and baby, and her work as an advocate since recovering from TB.

Tuberculosis

This information sheet  provides a comprehensive overview of tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis that primarily affects the lungs but can involve other parts of the body. It distinguishes between Latent TB Infection (LTBI), which is asymptomatic and non-infectious, and active TB disease, which can be pulmonary (infectious) or extrapulmonary (non-infectious).